article · Assam Journal of Internal Medicine
A bstract Background: Insulin resistance (IR) is an obesity and inflammation-associated condition driving the rising global prevalence of hypertension, type 2 diabetes mellitus (T2DM), and dyslipidemia. It is a modifiable risk factor for cardiometabolic disease due to its association with sedentary lifestyle and smoking. Aims: To assess IR and its associations in T2DM. Materials and Methods: This cross-sectional study analyzed 200 T2DM patients’ data and assessed its correlates and predictors using logistic regression. Statistical analysis used: Statistical Package for Social Sciences 26. Results: The mean age of the 200 participants was 58.96 ± 8.32 years, 19 (9.5%) were smokers and 54 (27%) had diabetes for more than 10 years. The waist–hip ratio was higher in women than men, P = 0.04. The hypertensives were older and had higher IR than those without hypertension, P = 0.04 and P < 0.001, respectively. The IR was positively correlated with the atherogenic index of plasma (AIP) and atherogenic coefficient (AQ), P = 0.04 and P < 0.001, respectively. Abdominal obesity, hypertension, hypertriglyceridemia, elevated triglyceride glycemic index (TGI), and low alpha lipoprotein (HDL) were more common in women than men. The elderly had higher AIP, TGI, and lower HDL, P < 0.001, P < 0.001, and P = 0.001, respectively. IR was associated with kidney dysfunction ( P = 0.02). Smoking (OR 1.93, 95% CI 1.15–2.26), hypertension (OR 5.84, 95% CI 3.17–7.28), AIP (OR 8.23, 95% CI 2.58–8.14), and AQ (OR 11.63, 95% CI 4.07–13.47) independently predicted IR. Conclusion: IR contributes majorly to the rising global prevalence of hypertension, T2DM, and dyslipidemia. Its association with sedentary lifestyles and smoking makes it a modifiable risk factor for cardiometabolic and renal disease. All efforts are needed to curtail its rising trend.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4103/ajoim.ajoim_19_24
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.